Charles Schwab Investment Management Inc. Has $8.43 Million Stock Holdings in RELX PLC $RELX

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Relx Plc by 16.5%, owning 167,175 shares worth approximately $8.4 million after acquiring an additional 23,692 shares in the first quarter.
• Following recent performance, Relx's stock opened at $47.80, with a 52-week range between $44.19 and $56.33, and a market capitalization of $87.69 billion.
• Relx recently announced a semi-annual dividend of $0.2634, resulting in a dividend yield of 170.0%, with a payout ratio of 28.49%.

Charles Schwab Investment Management Inc. grew its position in shares of RELX PLC (NYSE:RELX - Free Report) by 16.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 167,175 shares of the technology company's stock after purchasing an additional 23,692 shares during the quarter. Charles Schwab Investment Management Inc.'s holdings in RELX were worth $8,427,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Bank of America Corp DE increased its position in shares of RELX by 4.2% during the 4th quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock valued at $283,714,000 after purchasing an additional 253,107 shares during the period. Lazard Asset Management LLC increased its position in shares of RELX by 1.2% during the 4th quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company's stock valued at $191,868,000 after purchasing an additional 48,793 shares during the period. Ameriprise Financial Inc. increased its position in shares of RELX by 368.7% during the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock valued at $127,437,000 after purchasing an additional 2,208,119 shares during the period. Northern Trust Corp increased its position in shares of RELX by 51.6% during the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after purchasing an additional 745,532 shares during the period. Finally, Captrust Financial Advisors boosted its stake in shares of RELX by 9.6% during the 4th quarter. Captrust Financial Advisors now owns 1,209,743 shares of the technology company's stock worth $54,947,000 after acquiring an additional 105,946 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised RELX from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. One analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy".

RELX Price Performance

Shares of RELX traded down $0.32 during trading hours on Friday, hitting $46.64. 1,853,527 shares of the company were exchanged, compared to its average volume of 1,616,113. The company has a market capitalization of $85.56 billion, a PE ratio of 25.08, a PEG ratio of 3.04 and a beta of 0.87. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The firm has a fifty day simple moving average of $51.18 and a 200-day simple moving average of $51.37. RELX PLC has a one year low of $44.19 and a one year high of $56.33.

RELX Cuts Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th will be given a $0.2634 dividend. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend is Friday, August 8th. RELX's dividend payout ratio (DPR) is 28.49%.

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.